TY  - JOUR
AU  - Eslam, Mohammed
AU  - Newsome, Philip N
AU  - Sarin, Shiv K
AU  - Anstee, Quentin M
AU  - Targher, Giovanni
AU  - Romero-Gomez, Manuel
AU  - Zelber-Sagi, Shira
AU  - Wai-Sun Wong, Vincent
AU  - Dufour, Jean-François
AU  - Schattenberg, Jörn M
AU  - Kawaguchi, Takumi
AU  - Arrese, Marco
AU  - Valenti, Luca
AU  - Shiha, Gamal
AU  - Tiribelli, Claudio
AU  - Yki-Järvinen, Hannele
AU  - Fan, Jian-Gao
AU  - Grønbæk, Henning
AU  - Yilmaz, Yusuf
AU  - Cortez-Pinto, Helena
AU  - Oliveira, Claudia P
AU  - Bedossa, Pierre
AU  - Adams, Leon A
AU  - Ming-Hua, Zheng
AU  - Fouad, Yasser
AU  - Wah-Kheong, Chan
AU  - Mendez-Sanchez, Nahum
AU  - Sang Hoon, Ahn
AU  - Castera, Laurent
AU  - Bugianesi, Elisabetta
AU  - Ratziu, Vlad
AU  - George, Jacob
PY  - 2020
DO  - 10.1016/j.jhep.2020.03.039
UR  - http://hdl.handle.net/10668/15358
T2  - Journal of hepatology
AB  - The exclusion of other chronic liver diseases including "excess" alcohol intake has until now been necessary to establish a diagnosis of metabolic dysfunction-associated fatty liver disease (MAFLD). However, given our current understanding of the...
LA  - en
PB  - Elsevier BV
KW  - Cirrhosis
KW  - Diabetes
KW  - Diagnostic criteria
KW  - MAFLD
KW  - Metabolic
KW  - NAFLD
KW  - Obesity
KW  - Steatohepatitis
KW  - Causality
KW  - Consensus
KW  - Diabetes Mellitus, Type 2
KW  - Disease Progression
KW  - Fatty Liver
KW  - Humans
KW  - Liver Cirrhosis
KW  - Metabolic Diseases
KW  - Obesity
KW  - Terminology as Topic
TI  - A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.
TY  - research article
VL  - 73
ER  -